TGFB1 and neoplasm: Meanwhile, Met@Man-MPs treatment markedly increased the levels of pro-inflammation cytokines IFN-γ (Fig. 4l), TNF-α (Fig. 4m), and IL12p70 (Fig. 4n), while decreased the levels of anti-inflammation cytokine TGF-β (Fig. 4o) in tumor tissues.